Zenith Drugs Limited manufactures and trades in medicines. It provides a range of pharmaceutical formulations, such as ORS powder, liquid orals, ointments, creams, gels, liquid externals, capsules, and tablets, as well as injections. The company’s products are indicated for allergology, general analytics, infections, genetics, endocrinology, and microbiology. It operates in India, Costa Rica, Mauritius, Cambodia, Myanmar, Yemen, Sierra, Leone, Liberia, and Bhutan. The company was incorporated in 1956 and is based in Indore, India.
Metrics to compare | ZENH | Peers Peers - average of corresponding metrics from companies closely matching ZENH: MOREPENLAB, KOPRAN, 540694, ACCENTMIC, 524790 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZENHPeersSector |
---|---|---|---|---|
P/E Ratio | 18.2x | 26.7x | −0.6x | |
PEG Ratio | −0.72 | 0.23 | 0.00 | |
Price/Book | - | 3.1x | 2.6x | |
Price / LTM Sales | 1.0x | 2.3x | 3.3x | |
Upside (Analyst Target) | - | 11.5% | 40.0% | |
Fair Value Upside | Unlock | 4.7% | 4.7% | Unlock |